News and Updates

Displaying 1 - 25 of 53

New NIST reference material to support mRNA therapeutics

July 14, 2025

Messenger RNA ( mRNA)-based therapies require a careful assessment of Critical Quality Attributes (CQAs) using various analytical techniques, to ensure

An RM for Assessing the Performance of Bioprocess Measurement Systems

June 30, 2025

After the release of NISTmAb RM 8671, the biopharmaceutical community noted that a monoclonal antibody (mAb) producing Chinese hamster ovary line (CHO) cell

SURF student Zainab Altamimi, who wears a hijab, stands in a lab with safety glasses and gloves on as she holds a micropipette in one hand and a vial in the other.

Spotlight: SURF Student Zainab Altamimi Spends Her Summer Researching the Capsules and Tablets in 3D Drug Printing

August 6, 2024

From antibiotics to insulin, there have been shortages of many lifesaving drugs in recent years, requiring doctors and patients to adapt treatment plans. But

A gloved hand holds a glass flask partly full of pinkish liquid, with a label in marker saying in part "NISTCHO RCB."

NIST, Partners Develop Living Reference Material for Producing Monoclonal Antibodies

January 11, 2023

Publicly available NISTCHO cell line expands the biomanufacturing and research applications of NIST’s monoclonal antibody standard, NISTmAb.

nucleic acid nanotechnology illustration

A Revolution Still in the Making: NIST Researchers Chart the Future of Nucleic Acid Nanotechnology

October 27, 2022

Trapped in a microscopic cage made of strands of DNA, molecules of a life-saving drug course through the bloodstream of a cancer patient. Only when receptors on

An illustration of a Scrabble board, including the words "CRISPR," "EDIT," and "TEMPLATE."

Genome Editing Terminology Is Standardized in NIST-Led Effort

August 11, 2022

It’s good to be clear about your intentions, especially if you intend to edit someone’s DNA.

NIST Issues the First Standard Reference Material for the Quantitative Analysis of Glycans

August 3, 2022

NIST Standard Reference Material (SRM) 3655 helps biopharmaceutical manufacturers perform measurements of glycan molecules in their protein drug products

Where Once Were Black Boxes, NIST’s New LANTERN Illuminates

June 22, 2022

Researchers at the National Institute of Standards and Technology (NIST) have developed a new statistical tool that they have used to predict protein function.

NIST Awards Funding to Strengthen Advanced Manufacturing for Microelectronics, Digital and Biomanufacturing

April 1, 2022

GAITHERSBURG, Md. — The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has awarded a total of $1.2 million to four

Commerce Department Awards $54 Million in American Rescue Act Grants to Increase Access to Advanced Manufacturing Opportunities

February 28, 2022

GAITHERSBURG, Md. — The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has awarded nearly $54 million in grants for 13 high

Two people in coveralls and hair covers check the readouts on laboratory equipment.

Secretary Raimondo Announces $153 Million to Promote Innovation in Biopharmaceutical Manufacturing

July 14, 2021

WASHINGTON — The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has made two awards totaling $153 million to the National

Identifying Individual Molecules: NIST Study Suggests How to Build a Better ‘Nanopore’ Biosensor

April 27, 2021

Researchers have spent more than three decades developing and studying miniature biosensors that can identify single molecules. In five to 10 years, when such

A shadow image with purple background of a male scientist looking at a microscope

The Ins and Outs of a NIST Patent

April 6, 2021

Electron or X-Ray Beam Lithography in Liquids Description These days, the fabrication of 2D and 3D structures out of liquid, biocompatible, hydrogel solutions

NIST Puts New Biopharmaceutical Quality Control Method to the Test

March 29, 2021

A new method for monitoring biopharmaceutical product quality was recently put to the test by The National Institute of Standards and Technology (NIST) and 28

NIST Publishes a Beginner’s Guide to DNA Origami

January 8, 2021

In a technique known as DNA origami, researchers fold long strands of DNA over and over again to construct a variety of tiny 3D structures, including miniature

NIST Scientists Get Soft on 3D Printing

September 22, 2020

Researchers at the National Institute of Standards and Technology (NIST) have developed a new method of 3D-printing gels and other soft materials. Published in

NIST Awards $8.9 Million to Fund High-Impact Biopharmaceutical Manufacturing Projects to Battle COVID-19

May 27, 2020

Authorized by the CARES Act, the funding will go to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL).

Stem Cells and AI: Better Together

November 18, 2019

One day in the future when you need medical care, someone will examine you, diagnose the problem, remove some of your body’s healthy cells, and then use them to

Probing the Origin of Alzheimer’s . . . with Transistors

August 7, 2019

A prime suspect in the onset of Alzheimer’s and Parkinson’s diseases is a normally benign enzyme that is essential to proper development of the nervous system

Dr. Nicole L. Ritzert is pictured in her ADA lab.

NIST Continues 1920s CRADA Partnership with the American Dental Association

August 1, 2019

The interagency research, which has led to dental products such as tooth-colored composites, the front surface dental mirror, the panoramic x-ray machine

NIST 2D NMR ‘Fingerprinting’ Study Gives Biopharmaceutical Sector New Power to Assure High Quality Monoclonal Antibody Therapeutics

December 20, 2018

Researchers at the National Institute of Standards and Technology (NIST) recently completed a large international study * that establishes two-dimensional

Biomanufacturing